β-Lactones as a new class of cysteine proteinase inhibitors: inhibition of hepatitis A virus 3C proteinase by N-Cbz-serine β-Lactone

Organic Letters

Volumn 1, Issue 5, 1999, Pages 803-806

  Lall, Manjinder S ^a   Karvellas, Constantine ^a   Vederas, John C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001014188     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol990148r     Document Type: Article

References (49)

1. For reviews, see: (a) Roose, J. P.; Van Noorden, C. J. F. J. Lab. Clin. Med. 1995, 125, 433-441.
2. (b) Otto, H.-H.; Schirmeister, T. Chem. Rev. 1997, 97, 133-171.
3. (c) Thompson, S. K. Bioorg. Med. Chem. 1999, 7, vii and following articles in issue.
4. Malcolm, B. A. Protein Sci. 1995, 4, 1439-1445.
5. (a) Bergmann, E. M.; James, M. N. G. In Proteinases of Infectious Agents; Dunn, B., Ed.; Academic Press: San Diego, CA, 1999; pp 139-163.
6. (b) Gorbalenya, A. E.; Snijder, E. J. Perspect. Drug Discov. Design 1996, 6, 64-86.
7. Schultheiss, T.; Sommergruber, W.; Kusov, Y.; Gauss-Müller, V. J. Virology 1995, 69, 1727-1733.
8. Dougherty, W. G.; Semler, B. L. Microbiol. Rev. 1993, 57, 781-822.
9. Bergmann, E. M.; Mosimann, S. C.; Chernaia, M. M.; Malcolm, B. A.; James, M. N. G. J. Virol. 1997, 71, 2436-2448.
10. Matthews, D. A.; Smith, W. W.; Ferre, R. A.; Condon, B.; Budahazi, G.; Sisson, W.; Villafranca, J. E.; Janson, C. A.; McElroy, H. E.; Gribskov, C. L.; Worland, S. Cell 1994, 77, 761-771.
11. Mosimann, S. C.; Cherney, M. M.; Sia, S.; Plotch, S.; James, M. N. G. J. Mol. Biol. 1997, 273, 1032-1047.
12. Malcolm, B. A.; Lowe, C.; Shechosky, S.; McKay, R. T.; Yang, C. C.; Shah, V. J.; Simon, R. J.; Vederas, J. C.; Santi, D. V. Biochemistry 1995, 34, 8172-8179.
13. Webber, S. E.; Okano, K.; Little, T. L.; Reich, S. H.; Xin, Y.; Fuhrman, S. A.; Matthews, D. A.; Love, R. A.; Hendrickson, T. F.; Patick, A. K.; Meador, J. W., III; Ferre, R. A.; Brown, E. L.; Ford, C. E.; Binford, S. L.; Worland, S. T. J. Med. Chem. 1998, 41, 2786-2805.
14. Morris, T. S.; Frormann, S.; Shechosky, S.; Lowe, C.; Lall, M. S.; Gauss-Müller, V.; Purcell, R. H.; Emerson, S. U.; Vederas, J. C.; Malcolm, B. A. Bioorg. Med. Chem. 1997, 5, 797-807.
15. Skiles J. W.; McNeil, D. Tetrahedron Lett. 1990, 31, 7277-7280.
16. Webber, S. E.; Tikhe, J.; Worland, S. T.; Fuhrman, S. A.; Hendrickson, T. F.; Matthews, D. A.; Love, R. A.; Patick, A. K.; Meador, J. W.; Ferre, R. A.; Brown, E. L.; DeLisle, D. A.; Ford, C. E.; Binford, S. L. J. Med. Chem. 1996, 39, 5072-5082.
17. Wang, Q. M.; Johnson, R. B.; Jungheim, L. N.; Cohen, J. D.; Villarreal, E. C. Antimicrob. Agents Chemother. 1998, 42, 916-920.
18. Dragovich, P. S.; Webber, S. E.; Babine, R. E.; Fuhrman, S. A.; Patick, A. K.; Matthews D. A.; Lee, C. A.; Reich, S. H.; Prins, T. J.; Marakovits, J. T.; Littlefield, E. S.; Zhuo, R.; Tikhe, J.; Ford, C. E.; Wallace, M. B.; Meador, J. W., III; Ferre, R. A., Brown, E. L.; Binford, S. L.; Harr, J. E. V.; DeLisle, D. M.; Worland, S. T. J. Med. Chem. 1998, 41, 2806-2818
19. Kong, J.; Venkatraman, S.; Furness, K.; Nimkar, S.; Shepherd, T. A.; Wang, Q. M.; Aubé, J.; Hanzlik, R. P. J. Med. Chem. 1998, 41, 2579-2587
20. Dragovich, P. S.; Prins, T. J.; Zhuo, R.; Webber, S. E.; Marakovits, J. T.; Fuhrman, S. A.; Patick, A. K.; Matthews D. A.; Lee, C. A.; Ford, C. E.; Burke, B. J.; Rejto, P. A.; Hendrickson, T. F.; Tuntland, T.; Brown, E. L.; Meador, J. W., III; Ferre, R. A.; Harr, J. E. V.; Worland, S. T. J. Med. Chem. 1999, 42, 1213-1224.
21. Sham, H. L.; Rosenbrook, W.; Kati, W.; Betebenner, D. A.; Wideburg, N. E.; Saldivar, A.; Plattner, J. J.; Norbeck, D. W. J. Chem. Soc., Perkin Trans. 1 1995, 1081-1082.
22. McKendrick, J. E.; Frormann, S.; Luo, C.; Semchuk, P.; Vederas, J. C.; Malcolm, B. A. Int. J. Mass Spectrom. 1998, 176, 113-124.
23. Venkatraman, S.; Kong, J.; Nimkar, S.; Wang, Q. M.; Aubé, J.; Hanzlik, R. P. Bioorg. Med. Chem. Lett. 1999, 9, 577-580.
24. Yanting, H.; Malcolm, B. A.; Vederas, J. C. Bioorg. Med. Chem. 1998, 7, 607-619.
25. Tetrahydrolipstatin (Orlistat) inactivates human pancreatic lipase by acylating a serine hydroxyl of the enzyme: (a) Lüthi-Peng, Q.; Märki, H. P.; Hadváry, P. FEBS Lett. 1992, 299, 111-115.
26. (b) Hadváry, P.; Sidler, W.; Meister, W.; Vetter, W.; Wolfer, H. J. Biol. Chem. 1991, 266, 2021-7027.
27. (c) Other β-lactones may also acylate related lipases: Kocienski, P. J.; Pelotier, B.; Pons, J.-M.; Prideaux, H. J. Chem. Soc., Perkin Trans. 1 1998, 1373-1382 and references therein.
28. β-Lactones such as the antibiotic F-244 (1233A) may acylate a cysteine residue of HMG CoA synthase: Romo, D.; Harrison, P. H. M.; Jenkins, S. I.; Riddoch, R. W.; Park, K.; Yang, H. W.; Zhao, C.; Wright, G. D. Bioorg. Med. Chem. 1998, 6, 1255-1272. Mayer, R. J.; Louis-Flamberg, P.; Elliott, J. D.; Fisher, M.; Leber, J. Biochem. Biophys. Res. Commun. 1990. 169, 610-616.
29. β-Lactones such as the antibiotic F-244 (1233A) may acylate a cysteine residue of HMG CoA synthase: Romo, D.; Harrison, P. H. M.; Jenkins, S. I.; Riddoch, R. W.; Park, K.; Yang, H. W.; Zhao, C.; Wright, G. D. Bioorg. Med. Chem. 1998, 6, 1255-1272. Mayer, R. J.; Louis-Flamberg, P.; Elliott, J. D.; Fisher, M.; Leber, J. Biochem. Biophys. Res. Commun. 1990. 169, 610-616.
30. Omuralide, the β-lactone derived from lactacystin, has been shown to inhibit the 20S proteosome by O-acylation of a threonine residue: (a) Corey, E. J.; Li, W. D. Z. Chem. Pharm. Bull. 1999, 47, 1-10.
31. (b) Corey, E. J.; Li, W. D. Z.; Nagamitsu, T.; Fenteany, G. Tetrahedron 1999, 55, 3305-3316.
32. For reviews of natural β-lactones, see: (a) Lowe, C.; Vederas, J. C. Org. Prep. Proced. Int. 1995, 27, 305-346.
33. (b) Pommier, A.; Pons, J. M. Synthesis 1995, 7, 729-744.
34. (c) For a review of syntheses of β-lactones, see: Yang, H. W.; Romo, D. Tetrahedron 1999, 55, 6403-6434.
35. For a discussion of reactions and leading references, see: (a) Pansare, S. V.; Huyer, G.; Arnold, L. D.; Vederas, J. C. Org. Synth. 1991, 70, 1-9.
36. (b) Pansare, S. V.; Arnold, L. D.; Vederas, J. C. Org. Synth. 1991, 70, 10-17.
37. (c) Arnold, L. D.; Kalantar, T. H.; Vederas, J. C. J. Am. Chem. Soc. 1985, 107, 7105-7109.
38. (d) Arnold, L. D.; May, R. G.; Vederas, J. C. J. Am. Chem. Soc. 1988, 110, 2237-2241.
39. (a) Jewell, D. A.; Swietnicki, W.; Dunn, B. M.; Malcolm, B. A. Biochemistry 1992, 31, 7862-7869.
40. Kinetic constant were obtained as described m the following: Kitz, R.; Wilson, I. B. J. Biol. Chem. 1962, 237, 3245-3249.
41. Segel, I. H. In Enzyme Kinetics; John Wiley & Sons: New York, 1975; pp 125-135.
42. m of 2.1 mM at pH 7.5; see ref 2.
43. (a) For an example of water attack at the γ-position of homoserine lactone, see: Schwab, J. M.; Ray, T.; Ho, C.-K. J. Am. Chem. Soc. 1989, 111, 1057-1063.
44. (b) For examples of thiol attack at the γ-position of γ-lactones, see: Vaughan, W. R.; Baumann, J. B. J. Org. Chem. 1962, 27, 739-741 and references therein.
45. (c) For general discussions of ring opening of γ-lactones, see: Aldridge, D. C.; Nicholson, S.; Taylor, P. J. J. Chem. Soc., Perkin Trans. 2 1997, 1929-1938. Huisgen, R.; Ott, H. Tetrahedron 1959, 6, 253-267.
46. (c) For general discussions of ring opening of γ-lactones, see: Aldridge, D. C.; Nicholson, S.; Taylor, P. J. J. Chem. Soc., Perkin Trans. 2 1997, 1929-1938. Huisgen, R.; Ott, H. Tetrahedron 1959, 6, 253-267.
47. 13C), (68 ppm); N-(benzyloxycarbonyl)-S-methyl-L-cysteine 10, (37 ppm); N-(benzyloxycarbonyl)-L-serine ethyl thioester 11, (64 ppm); N-(benzyloxycarbonyl)-L-serine methyl ester 12, (62 ppm); N-(benzyloxycarbonyl)-O-methyl-D-serine 13, (73 ppm). An Inova 600 Varian NMR spectrometer was used to obtain HMQC spectra.
48. Kim, D. H.; Ryoo, J. J. Bioorg. Med. Chem. Lett. 1995, 5, 1287-1292.
49. Corey, E. J.; Li, W.; Nagamitsu, T. Angew. Chem., Int. Ed. Engl. 1998, 37, 1676-1679.